TITLE

Avita Medical Reports Third Quarter- and Nine-Month Financial Results

PUB. DATE
May 2011
SOURCE
Biomedical Market Newsletter;5/5/2011, p112
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that Avita Medical Ltd., a regenerative medicine company, has released its financial results for the 3rd quarter and nine months ending, ending March 31, 2011, in Great Britain. According to William Dolphin, chief executive officer (CEO) of Avita Medical, the sales of their ReCell Spray-On-Skin regenerative product have shown strong growth for consecutive quarters. A brief description of the company is provided, including its ReCell Spray-On-Skin product.
ACCESSION #
60795059

 

Share

Other Topics